Skip to main content
. 2021 Dec 8;13(12):4384. doi: 10.3390/nu13124384

Table 2.

Descriptive measures of influential genera expressed as a percentage of total gut bacteria counts pre and post intervention in young women, by treatment group.

Measure T1 M (SD) T2 M (SD) M (SD)
GOS n = 21
Aestuariispira −3.30 (1.54) −2.77 (2.35) 0.54 (1.82)
Bacteroides 5.69 (1.13) 5.49 (1.53) −0.20 (0.71)
Barnesiella 1.23 (2.39) 1.82 (2.25) 0.59 (1.51)
Bifidobacterium 3.82 (1.96) 4.62 (1.37) 0.80 **B (1.28)
Desulfovibrio −1.45 (2.30) −1.30 (2.57) 0.15 (0.87)
Gardnerella −3.83 (0.65) −3.64 (0.75) 0.18 (0.59)
Peptoniphilus −3.32 (1.10) −3.36 (1.21) −0.04 (1.41)
Sporobacter 0.11 (1.75) 0.48 (1.72) 0.37 (1.15)
Placebo n = 23
Aestuariispira −3.30 (2.04) −3.59 (1.26) −0.32 (1.40)
Bacteroides 5.11 (1.15) 5.30 (1.23) 0.24 (0.59)
Barnesiella 1.59 (2.06) 1.19 (2.17) −0.32 *B (1.58)
Bifidobacterium 3.93 (1.88) 4.14 (2.18) 0.01 (2.05)
Desulfovibrio −1.72 (2.44) −2.34 (2.25) −0.56 (2.00)
Gardnerella −3.73 (1.15) −2.97 (1.59) 0.75 **B (1.03)
Peptoniphilus −3.24 (1.47) −2.50 (1.63) 0.70 (1.90)
Sporobacter 0.48 (1.72) 0.23 (2.11) −0.17 (0.89)

Note. Average (mean, M) abundance of significant bacteria as a percentage of total gut bacteria composition (%) at T1 and T2, and difference (T2 minus T1) with standard deviations (SD) presented for each group separately. Significance tests evaluating the change across time were calculated and are denoted by asterisks; * p < 0.05, ** p < 0.01. Letters denote paired sample test used; B significance value from Wilcoxon signed rank test for non-gaussian response distributions, identified by significant Shapiro-Wilk test of normality across groups. GOS = galacto-oliogosaccharides. Arrows are illustrative indications of change direction ↑ increase, ↓ decrease.